128 related articles for article (PubMed ID: 37541472)
21. How Can Biomolecules Improve Mucoadhesion of Oral Insulin? A Comprehensive Insight using
Amaral M; Martins AS; Catarino J; Faísca P; Kumar P; Pinto JF; Pinto R; Correia I; Ascensão L; Afonso RA; Gaspar MM; Charmier AJ; Figueiredo IV; Reis CP
Biomolecules; 2020 Apr; 10(5):. PubMed ID: 32349416
[TBL] [Abstract][Full Text] [Related]
22. Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS).
Bhavsar MD; Amiji MM
J Control Release; 2007 Jun; 119(3):339-48. PubMed ID: 17475358
[TBL] [Abstract][Full Text] [Related]
23. Brij-stabilized zein nanoparticles as potential drug carriers.
Gagliardi A; Voci S; Salvatici MC; Fresta M; Cosco D
Colloids Surf B Biointerfaces; 2021 May; 201():111647. PubMed ID: 33639515
[TBL] [Abstract][Full Text] [Related]
24. Anticancer drug-loaded gliadin nanoparticles induce apoptosis in breast cancer cells.
Gulfam M; Kim JE; Lee JM; Ku B; Chung BH; Chung BG
Langmuir; 2012 May; 28(21):8216-23. PubMed ID: 22568862
[TBL] [Abstract][Full Text] [Related]
25. Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease.
Shrestha N; Xu Y; Prévost JRC; McCartney F; Brayden D; Frédérick R; Beloqui A; Préat V
Acta Biomater; 2022 Mar; 140():561-572. PubMed ID: 34923097
[TBL] [Abstract][Full Text] [Related]
26. The in vivo fate of nanoparticles and nanoparticle-loaded microcapsules after oral administration in mice: Evaluation of their potential for colon-specific delivery.
Ma Y; Fuchs AV; Boase NR; Rolfe BE; Coombes AG; Thurecht KJ
Eur J Pharm Biopharm; 2015 Aug; 94():393-403. PubMed ID: 26117186
[TBL] [Abstract][Full Text] [Related]
27. Development, Characterization and Resveratrol Delivery of Hollow Gliadin Nanoparticles: Advantages over Solid Gliadin Nanoparticles.
Li D; Wei Z; Li X
Foods; 2023 Jun; 12(13):. PubMed ID: 37444174
[TBL] [Abstract][Full Text] [Related]
28. Preparation of tetanus toxoid and ovalbumin loaded gliadin nanoparticles for oral immunization.
Kajal H; Misra A
J Biomed Nanotechnol; 2011 Feb; 7(1):211-2. PubMed ID: 21485875
[TBL] [Abstract][Full Text] [Related]
29. Biodistribution and pharmacokinetics of thiolated chitosan nanoparticles for oral delivery of insulin in vivo.
Sudhakar S; Chandran SV; Selvamurugan N; Nazeer RA
Int J Biol Macromol; 2020 May; 150():281-288. PubMed ID: 32057846
[TBL] [Abstract][Full Text] [Related]
30. Anti-Helicobacter pylori effect of mucoadhesive nanoparticles bearing amoxicillin in experimental gerbils model.
Umamaheshwari RB; Ramteke S; Jain NK
AAPS PharmSciTech; 2004 Apr; 5(2):e32. PubMed ID: 15760090
[TBL] [Abstract][Full Text] [Related]
31. The mucoadhesive and gastroretentive properties of hydrophobin-coated porous silicon nanoparticle oral drug delivery systems.
Sarparanta MP; Bimbo LM; Mäkilä EM; Salonen JJ; Laaksonen PH; Helariutta AM; Linder MB; Hirvonen JT; Laaksonen TJ; Santos HA; Airaksinen AJ
Biomaterials; 2012 Apr; 33(11):3353-62. PubMed ID: 22285465
[TBL] [Abstract][Full Text] [Related]
32. Oxidized Chitin Nanocrystals Greatly Strengthen the Stability of Resveratrol-Loaded Gliadin Nanoparticles.
Zhong W; Zhi Z; Zhao J; Li D; Yu S; Duan M; Xu J; Tong C; Pang J; Wu C
J Agric Food Chem; 2022 Oct; 70(42):13778-13786. PubMed ID: 36196864
[TBL] [Abstract][Full Text] [Related]
33. Integration of physicochemical, molecular dynamics, and in vitro evaluation of electrosprayed γ-oryzanol-loaded gliadin nanoparticles.
Sharif N; Golmakani MT; Hajjari MM
Food Chem; 2022 Nov; 395():133589. PubMed ID: 35779508
[TBL] [Abstract][Full Text] [Related]
34. Lyophilized insulin nanoparticles prepared from quaternized N-aryl derivatives of chitosan as a new strategy for oral delivery of insulin: in vitro, ex vivo and in vivo characterizations.
Mahjub R; Radmehr M; Dorkoosh FA; Ostad SN; Rafiee-Tehrani M
Drug Dev Ind Pharm; 2014 Dec; 40(12):1645-59. PubMed ID: 24093431
[TBL] [Abstract][Full Text] [Related]
35. Mucoadhesion and the gastrointestinal tract.
Varum FJ; McConnell EL; Sousa JJ; Veiga F; Basit AW
Crit Rev Ther Drug Carrier Syst; 2008; 25(3):207-58. PubMed ID: 18540839
[TBL] [Abstract][Full Text] [Related]
36. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers.
Wang Y; Zhao Y; Cui Y; Zhao Q; Zhang Q; Musetti S; Kinghorn KA; Wang S
Acta Biomater; 2018 Jan; 65():405-416. PubMed ID: 29037897
[TBL] [Abstract][Full Text] [Related]
37. Absorption, distribution, metabolism and excretion of selenium following oral administration of elemental selenium nanoparticles or selenite in rats.
Loeschner K; Hadrup N; Hansen M; Pereira SA; Gammelgaard B; Møller LH; Mortensen A; Lam HR; Larsen EH
Metallomics; 2014 Feb; 6(2):330-7. PubMed ID: 24413471
[TBL] [Abstract][Full Text] [Related]
38. Biocompatible gliadin-sericin complex colloidal particles used for topical delivery of the antioxidant phloretin.
Luo FC; Zhu JJ; You XM; Yang XQ; Yin SW
Colloids Surf B Biointerfaces; 2023 May; 225():113244. PubMed ID: 36905836
[TBL] [Abstract][Full Text] [Related]
39. Gliadin Nanoparticles Induce Immune Tolerance to Gliadin in Mouse Models of Celiac Disease.
Freitag TL; Podojil JR; Pearson RM; Fokta FJ; Sahl C; Messing M; Andersson LC; Leskinen K; Saavalainen P; Hoover LI; Huang K; Phippard D; Maleki S; King NJC; Shea LD; Miller SD; Meri SK; Getts DR
Gastroenterology; 2020 May; 158(6):1667-1681.e12. PubMed ID: 32032584
[TBL] [Abstract][Full Text] [Related]
40. Surface design of nanocarriers: Key to more efficient oral drug delivery systems.
Spleis H; Sandmeier M; Claus V; Bernkop-Schnürch A
Adv Colloid Interface Sci; 2023 Mar; 313():102848. PubMed ID: 36780780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
